GSA CAPITAL PARTNERS LLP - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 60 filers reported holding IRADIMED CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IRADIMED CORP
ValueSharesWeighting
Q2 2019$231,000
-40.8%
11,301
-18.7%
0.03%
-35.0%
Q1 2019$390,000
+34.9%
13,896
+17.8%
0.04%
+21.2%
Q4 2018$289,000
-24.3%
11,796
+14.6%
0.03%
+57.1%
Q3 2018$382,000
+77.7%
10,296
+4.0%
0.02%
+75.0%
Q2 2016$215,000
-69.0%
9,902
-72.7%
0.01%
-72.7%
Q1 2016$694,000
-50.7%
36,232
-27.8%
0.04%
-36.2%
Q4 2015$1,407,000
+215.5%
50,203
+174.3%
0.07%
+213.6%
Q3 2015$446,00018,3020.02%
Other shareholders
IRADIMED CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders